Efficacy and Safety of a Novel Tazarotene 0.045% Lotion in Females and Males with Moderate-to-Severe Acne

Main Article Content

H Baldwin
L Green
L Kircik
E Guenin


Tazarotene, Acne


Abstract not available.


1. Skroza N, et al. J Clin Aesthet Dermatol. 2018;11(1):21-25.
2. Collier CN, et al. J Am Acad Dermatol. 2008;58(1):56-9.
3. Gorelick J, et al. J Dermatol Nurses Assoc. 2015;7(3):154-162.
4. Tanghetti EA, et al. J Drugs Dermatol. 2019;18(6):542.

Most read articles by the same author(s)

1 2 > >>